Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Interest Paid (2025 - 2026)

Updated

Vistagen Therapeutics' Interest Paid was $5,000 in fiscal Q4 2026 (quarter ended Mar 31, 2026), down 44.4% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Interest Paid (2025 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Interest Paid at Vistagen Therapeutics came in at $33,000.

  • Interest Paid shows a five-year compound annual growth rate of 19.9% (FY2021 to FY2026).
  • In earlier fiscal years, Interest Paid was $300.00 in FY2022 (-97.7%).
  • Per Business Quant data, VTGN's Interest Paid in the three fiscal quarters before Q4 2026 was $9,000 (Q3 2026), $13,000 (Q2 2026) and $6,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5,000.00
Dec 31, 2025 9,000.00
Sep 30, 2025 13,000.00
Jun 30, 2025 6,000.00
API Access

Vistagen Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=VTGN&period=max&api_key=YOUR_API_KEY